PharmaLogic Services

PharmaLogic Development, Inc. provides services to the pharmaceutical and biomedical industries through the drug development process. In planning the optimum usage of resources, skills, and commercially available resources, our support ranges from candidate selection through NDA, to marketing support.

PRIMARY THERAPEUTIC AREAS

  • Ophthalmology
  • Dermatology
  • Neurology

REGULATORY

  • NDA/Preclinical and clinical reports & summaries
  • FDA client representation (pre-IND, pre-NDA meetings)
  • Literature Reviews

CLINICAL TRIALS

  • Clinical Trial Outlines
  • Protocol Design
  • Biostatistical Evaluation
  • Medical Final Reports

PRODUCT RESEARCH AND DEVELOPMENT

  • Preclinical Data Review
  • Candidate Selection
  • Licensing Representation
  • Business Plans
  • IND Preparation
  • Literature and Patent Searching

MARKETING AND MANUFACTURING

  • Medical Communication
  • Scientific/Medical Abstracts & Posters
  • Public Presentations
  • Market Research focus groups
  • Competitor Intelligence
  • Market Overview

As we reflect back on our more than 25 years, some of our key accomplishments are:

  • Some of our key accomplishments are: Played a key role in the development of over 40 ophthalmic, dermatologic, and neurologic approved products
  • NDA Firsts: First treatment for macular degeneration, First soft drug, First and second intravitreal drug delivery system
  • Served over 400 clients in four continents on thousands of projects
  • Contributed to over 100 IND and IDE submissions
  • Organized and lead clients on scores of meetings with regulatory agencies worldwide
  • Serving as a director of a publicly traded ophthalmic pharmaceutical firm, including raising over $100 million in financing
  • Served as agent for a multi-million dollar licensing arrangement
  • Created several business plans, including one funded at over $80 million
  • Had our 225th paper accepted to a peer-reviewed journal
  • Published over 60 additional papers as medical writer, plus others as editor for non-English speakers
  • Performed 100’s of literature and patent searches, including support for patent arbitration

List of products on which PharmaLogic has made major contributions:

Acular® (Ketorolac)

Alamast® (Pemirolast)

Alomide® (Lodoxamide)

Alphagan® (Brimonidine)

Alrex® (Loteprednol etabonate)

Aquaflow®

Array® Multifocal IOL

AzaSite™ (Azithromycin)

Azopt® (Brinzolamide)

Bepreve™ (Bepotastine)

Besivance™ (besifloxacin)

Betagan®, Mirol® (Levobunolol)

Betaseron® (Beta-1b interferon)

Betoptic-S® (Betaxolol)

Bion Tears®

Botox® (Botulinum toxin type A)

Buphenyl® (Sodium phenylbutyrate)

CellCept (Mycophenolate mofetil)

Chibroxin® (Norfloxacin)

Clindagel® (Clindamycin phosphate gel)

Differin® (Adapalene)

Durezol® (Difluprednate)

FML-Forte ® (Fluorometholone)

Istalol(® (Timolol maleate)

iStent™

Jetrea® (ocriplasmin)

Keracor 116

Kyprolis® (carfilzomib)

Lotemax® (Loteprednol etabonate)

Luxiq® (Betamethasone valerate foam 0.12% )

Myobloc® (Botulinum toxin type B)

Myrbetriq® (mirabegron)

Ocufen® (Flurbiprofen)

Ocupress® (Carteolol)

Omidria® (phenylephrine/ketorolac)

Optipranolol® (Metipranolol)

Optivar® (Azelastine)

Paxene® (Paclitaxel)

Rescula® (Unoprostone isopropyl)

Restasis® (Cyclosporine)

Retisert® (Fluocinolone acetonide)

RxSight Light Adjustable Lens

Technolas Laser

Travatan® (Travoprost)

Trusopt (Dorzolamide)

Visudyne® (Verteprofin)

Vitrasert® (Ganciclovir)

Vitravene® (Formivirsen)

Xiidra® (Lifitegrast)

Zaditor® (Ketotifen)

Zanaflex® (Tizandine)

Zylet® (Loteprednol etabonate/tobramycin)

PharmaLogic has built its reputation on the following principles:

HIGH ETHICAL VALUES
CONFIDENTIALITY
DEDICATED COMMITMENT TO CLIENTS
QUALITY SERVICE
TECHNICAL EXPERTISE

As we reflect back on our more than 25 years, some of our key accomplishments are:

  • Some of our key accomplishments are: Played a key role in the development of over 40 ophthalmic, dermatologic, and neurologic approved products
  • NDA Firsts: First treatment for macular degeneration, First soft drug, First and second intravitreal drug delivery system
  • Served over 400 clients in four continents on thousands of projects
  • Contributed to over 100 IND and IDE submissions
  • Organized and lead clients on scores of meetings with regulatory agencies worldwide
  • Serving as a director of a publicly traded ophthalmic pharmaceutical firm, including raising over $100 million in financing
  • Served as agent for a multi-million dollar licensing arrangement
  • Created several business plans, including one funded at over $80 million
  • Had our 225th paper accepted to a peer-reviewed journal
  • Published over 60 additional papers as medical writer, plus others as editor for non-English speakers
  • Performed 100’s of literature and patent searches, including support for patent arbitration